Merck (MRK) EVP Zachary Jennifer Exercises Options, Sells Shares

What Happened

• Zachary Jennifer, EVP and General Counsel of Merck & Co. (MRK), exercised stock options on Aug 12, 2026 and sold shares the same day.
• She acquired 41,494 shares by exercising options at $117.89 (cost $4,891,728) and 13,433 shares at $84.71 (cost $1,137,909), then sold 80,315 shares in the open market for a weighted average price of $133.46, totaling $10,718,495.
• The filing also shows the related derivative positions (the options) as disposed at $0.00, reflecting the conversion/termination of those option awards upon exercise.

Key Details

• Transaction date: 2026-08-12; Form 4 filed 2026-08-13 (timely filing).
• Sale price range: $133.03 to $133.50; weighted average reported $133.46 (footnote F1).
• Exercise details: two option lots exercised — one vested in equal installments on 5/2/2024, 5/2/2025 and 5/2/2026 (F2); another vests in equal installments on 4/29/2026, 4/29/2027, and 4/29/2028 (F3).
• Shares owned after the transaction: not disclosed in the provided filing excerpt.
• No 10b5-1 plan, tax-withholding, or late-filing flags are noted in the provided information.

Context

• This appears to be a cashless/crossed sequence: options were exercised and shares were sold the same day rather than held long-term. Exercising options and immediately selling is a routine liquidity event for executives and does not by itself indicate a change in corporate outlook.
• For retail investors, purchases are generally more informative as a bullish signal; this set of transactions is primarily an exercise followed by an open-market sale (liquidation of exercised shares).